Cite
HARVARD Citation
Alexander, J. et al. (n.d.). OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab. Journal of Crohn's and colitis. pp. i022-i023. [Online].